# Comparison Between Lorazepam, Clonazepam and Clonazepam + Fosphenytoin for the Treatment of Out-of-hospital Generalized Status Epilepticus

> **NCT01870024** · PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 434 (actual)

## Conditions studied

- Status Epilepticus
- Epilepsy

## Interventions

- **DRUG:** Clonazepam
- **DRUG:** Fosphenytoin
- **DRUG:** Placebo
- **DRUG:** Lorazepam

## Key facts

- **NCT ID:** NCT01870024
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06-26
- **Primary completion:** 2018-02-23
- **Final completion:** 2018-02-23
- **Target enrollment:** 434 (ACTUAL)
- **Last updated:** 2018-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01870024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01870024, "Comparison Between Lorazepam, Clonazepam and Clonazepam + Fosphenytoin for the Treatment of Out-of-hospital Generalized Status Epilepticus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01870024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*